Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Chemistry
Emerging Technology
Immunoassays
Molecular Diagnostics
Pathology & AI
Pathology and AI: Page 2
Ibex, PathPresenter ink partnership
By
LabPulse.com staff writers
Ibex Medical Analytics (Ibex) and PathPresenter announced a partnership to enable wider use of AI-enabled digital pathology for their joint customers.
March 6, 2024
CAP releases updated guideline for validation of IHC assays
By
LabPulse.com staff writers
The College of American Pathologists (CAP) has updated its evidence-based guideline for analytic validation of immunohistochemical assays to provide increased accuracy and consistency in laboratory practices.
February 26, 2024
EnsoData’s AI-powered sleep study diagnostic gets FDA 510(k) clearance
By
LabPulse.com staff writers
EnsoData has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its machine learning-based diagnostic for sleep apnea and other sleep disorders that uses data from pulse oximetry devices.
February 26, 2024
Proscia receives 510(k) clearance from FDA for digital pathology solution
By
Matt Limb
Software company Proscia has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its digital pathology solution, Concentriq AP-Dx.
February 12, 2024
Opentrons Labworks unveils AI-powered workflow tools
By
Matt Limb
Lab automation and robotics firm Opentrons Labworks Inc has unveiled new tools intended to enhance the efficiency of research across genomics, proteomics, cell biology, and synthetic biology.
February 8, 2024
Hologic receives FDA clearance for digital cytology scanner platform in U.S.
By
Liz Carey
Acknowledging human papillomavirus (HPV) as a causative agent for cervical cancer, the new system is designed to complement molecular testing for HPV with cotesting for cervical cancer.
February 2, 2024
BD, Techcyte team for AI-enabled digital cervical cytology system
By
LabPulse.com staff writers
Becton Dickinson (BD) and Techcyte have announced a strategic collaboration agreement designed to, in time, add artificial intelligence (AI) to cervical cancer screening in the U.S.
January 30, 2024
FDA accepts 1st AI-based tool into Istand pilot program
By
LabPulse.com staff writers
A mental health assessment tool has become the first AI-powered tool to be accepted into the U.S. Food and Drug Administration's (FDA) Innovative Science and Technology Approaches for New Drugs (Istand) pilot program for advancing drug development.
January 26, 2024
Genetic-informed model improves prediction of blood cancer prognosis
By
Nick Paul Taylor
Researchers have used genetic, treatment, and clinical data to improve prediction of the prognosis of patients with multiple myeloma.
January 18, 2024
Imvaria gets FDA marketing authorization for Fibresolve
By
AuntMinnie.com staff writers
The U.S. Food and Drug Administration (FDA) has cleared Imvaria for the use of Fibresolve.
January 16, 2024
Gestalt adds Sagis Diagnostics for digital pathology and AI
By
LabPulse.com staff writers
Texas-based pathology group to implement digital pathology with AI using Gestalt platform.
January 11, 2024
Algorithm for drug repurposing unveiled at NeurIPS
By
LabPulse.com staff writers
A team at Klick Applied Sciences have created an artificial intelligence (AI) framework that can identify new indications for existing drugs.
January 2, 2024
Previous Page
Page 2 of 176
Next Page